Jean-Michel Molina Selected Research

Darunavir (Prezista)

1/2020	Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.
1/2018	Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial.
4/2015	Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study.
8/2013	High levels of atazanavir and darunavir in urine and crystalluria in asymptomatic patients.
4/2007	Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Michel Molina Research Topics

Disease

57	Infections 12/2022 - 04/2005
32	HIV Infections (HIV Infection) 01/2022 - 01/2003
14	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 12/2003
11	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2021 - 11/2005
10	Viremia 01/2022 - 11/2005
9	Coinfection 01/2022 - 04/2011
8	Tuberculosis (Tuberculoses) 01/2022 - 07/2008
7	Exanthema (Rash) 01/2021 - 11/2009
6	Nausea 01/2020 - 08/2008
6	Headache (Headaches) 01/2020 - 01/2014
6	Dizziness (Lightheadedness) 01/2019 - 07/2011
5	Chronic Hepatitis C 01/2017 - 07/2010
5	Lipodystrophy 01/2011 - 03/2002
5	Diarrhea 12/2007 - 06/2002
4	COVID-19 01/2022 - 12/2020
4	Microsporidiosis 01/2021 - 06/2002
4	Hepatitis B 09/2020 - 11/2015
4	Fibrosis (Cirrhosis) 03/2016 - 02/2006
4	Liver Cirrhosis (Hepatic Cirrhosis) 12/2015 - 02/2006
3	Inflammation (Inflammations) 03/2021 - 02/2020
3	Hepatitis 01/2019 - 04/2010
3	Immune Reconstitution Inflammatory Syndrome 03/2016 - 07/2008
2	Lymphoma (Lymphomas) 04/2022 - 12/2003
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2020
2	Disease Progression 01/2022 - 01/2021
2	Syphilis 01/2020 - 11/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 06/2005
2	Neoplasms (Cancer) 01/2019 - 06/2010
2	Hepatitis C 01/2016 - 04/2011
2	Anemia 01/2016 - 12/2014
2	Renal Insufficiency (Renal Failure) 08/2013 - 04/2003
2	Malaria 03/2012 - 05/2008
2	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2012 - 08/2005
2	Human Influenza (Influenza) 01/2012 - 07/2011
2	Hypersensitivity (Allergy) 05/2010 - 02/2008
2	Thrombocytopenia (Thrombopenia) 12/2009 - 06/2002

Drug/Important Bio-Agent (IBA)

27	RNA (Ribonucleic Acid)IBA 12/2022 - 04/2005
19	Tenofovir (Viread)FDA Link 01/2022 - 04/2003
19	Emtricitabine (Emtriva)FDA Link 10/2021 - 04/2005
15	efavirenz (Sustiva)FDA Link 01/2022 - 02/2006
15	Raltegravir Potassium FDA Link 01/2022 - 10/2009
14	Pharmaceutical PreparationsIBA 01/2022 - 05/2003
12	Ritonavir (Norvir)FDA Link 01/2020 - 04/2007
10	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2005
9	NucleosidesIBA 01/2022 - 03/2002
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2003
8	RacivirIBA 01/2022 - 05/2012
7	LipidsIBA 05/2022 - 01/2007
7	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 07/2010
6	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 06/2005
6	Rilpivirine (TMC-278)IBA 09/2020 - 07/2011
6	tenofovir alafenamideIBA 01/2020 - 01/2017
6	Atazanavir Sulfate (Reyataz)FDA Link 03/2014 - 08/2008
5	Doxycycline (Periostat)FDA LinkGeneric 10/2021 - 03/2012
5	Lamivudine (Epivir)FDA Link 01/2021 - 06/2014
5	doravirineIBA 01/2021 - 01/2018
5	Darunavir (Prezista)FDA Link 01/2020 - 04/2007
4	Reverse Transcriptase InhibitorsIBA 01/2022 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2009
4	AntigensIBA 01/2021 - 01/2015
4	AntibodiesIBA 01/2021 - 05/2003
4	elvitegravirIBA 10/2019 - 04/2013
4	TabletsIBA 01/2019 - 03/2014
4	abacavir (Ziagen)FDA Link 01/2018 - 02/2008
4	InterferonsIBA 03/2015 - 07/2010
4	Enfuvirtide (Fuzeon)FDA Link 09/2011 - 10/2009
3	dolutegravirIBA 01/2022 - 04/2015
3	VaccinesIBA 12/2020 - 03/2012
3	Integrase InhibitorsIBA 02/2020 - 03/2011
3	CreatinineIBA 01/2020 - 04/2003
3	CobicistatIBA 10/2019 - 04/2013
3	daclatasvirIBA 01/2017 - 09/2015
3	Lopinavir FDA Link 01/2015 - 08/2008
3	HLA-B Antigens (HLA-B)IBA 09/2013 - 02/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2011 - 12/2003
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 01/2021
2	IntegrasesIBA 01/2022 - 03/2011
2	EnzymesIBA 01/2021 - 01/2019
2	fumagillinIBA 01/2021 - 06/2002
2	cobicistat mixture with darunavirIBA 01/2019 - 01/2018
2	bictegravirIBA 01/2018 - 01/2018
2	Immunoglobulin G (IgG)IBA 03/2017 - 04/2012
2	SofosbuvirIBA 01/2017 - 03/2015
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 03/2016 - 01/2016
2	N- (8- aminohexyl)- 5- iodonaphthalene- 1- sulfonamide (W8)IBA 03/2016 - 01/2016
2	BilirubinIBA 01/2014 - 08/2008
2	HDL CholesterolIBA 01/2011 - 01/2007
2	etravirine (TMC-125)FDA Link 01/2010 - 11/2009

Therapy/Procedure

46	Therapeutics 01/2022 - 03/2002
14	Highly Active Antiretroviral Therapy (HAART) 03/2017 - 11/2005
6	Condoms (Condom) 11/2021 - 12/2015
5	Art Therapy 01/2022 - 01/2012
3	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2007
3	Duration of Therapy 01/2022 - 07/2010
2	Stem Cell Transplantation 04/2022 - 09/2007
2	Aftercare (After-Treatment) 01/2022 - 01/2017
2	Transplantation 04/2021 - 04/2014
2	Injections 09/2020 - 04/2005
2	Drug Therapy (Chemotherapy) 04/2015 - 12/2003
2	Blood Transfusion (Blood Transfusions) 12/2014 - 11/2008